1. Project
  2. GLIOVACC
  3. Organisations

Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands

Full project page

Organisations map overview


Powered by Chris Decubber BV